Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Small RNA-sequencing of bone marrow samples from acute myeloid leukemia patients chemoresistant (n=27) versus chemosensitive (n=20).

ABSTRACT: The aim of our research project is to identify microRNAs involved in chemoresistance in acute myeloid leukemia patients. We performed small RNA-sequencing on baseline bone marrow samples and compared chemoresistant versus chemosensitive patient samples.

INSTRUMENT(S): Illumina HiSeq 2000

ORGANISM(S): Homo sapiens

SUBMITTER: Violaine Havelange

PROVIDER: E-MTAB-8775 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Differential Gene Expression between Chemoresistant and Chemosensitive T24 Human Bladder Cancer Cells

Project description:This project employed proteomics to analyze protein expression profiles between chemoresistant and chemosensitive variants of the human bladder cancer T24 cell line. The objective was to identify key differentially expressed proteins and their associated signaling pathways involved in chemotherapy resistance. The findings aim to provide new insights and potential therapeutic targets for overcoming chemoresistance in bladder cancer.

2026-02-09 | PXD069140 | Pride

Transcriptomic comparison of chemosensitive and chemoresistant cells

Project description:First, in a model of xenografts induced with HT-29 human colon cancer cells, we demonstrated that the transcription factor NF-kB was involved in the resistance to CPT-11. Then, from one tumor treated with CPT-11 plus a NF-kB inhibitor, we established a resistant cell line to CPT-11. The aim of this study was to compare the expression of genes involved in the signaling pathway of NF-kB between the sensitive and the resistant cell lines and to identify other genes (target or not of NF-kB) which the expression was modified when the resistant phenotype was acquired. Human colon cancer cells chemosensitive (HT-29) versus human colon cancer cells chemoresistant (RIV) in a dye-swap experiment.

2012-08-23 | E-GEOD-23433 | biostudies-arrayexpress

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy

Project description:Chemotherapy (CT) resistance in ovarian cancer is broad and encompasses diverse, unrelated drugs, suggesting more than one mechanism of resistance. We aimed to analyze the gene expression patterns in primary serous epithelial ovarian cancer (EOC) samples displaying different responses to first-line CT in an attempt to identify specific molecular signatures associated with response to CT. Initially, the expression profiles of 15 chemoresistant serous EOC tumors [time to recurrence (TTR) ≤6 months] and 10 chemosensitive serous EOC tumors (TTR ≥30 months) were independently analyzed which allowed the identification of specific sets of differentially expressed genes that might be functionally implicated in the evolution of the chemoresistant or the chemosensitive phenotype. Our data suggest that the intrinsic chemoresistance in serous EOC cells may be attributed to the combined action of different molecular mechanisms and factors linked with drug influx and efflux and cell proliferation, as possible implications of other molecular events including altered metabolism, apoptosis and inflammation cannot be excluded. Next, gene expression comparison using hierarchical clustering clearly distinguished chemosensitive and chemo- resistant tumors from the 25 serous EOC samples (training set), and consecutive class prediction analysis was used to develop a 43-gene classifier that was further validated in an independent cohort of 15 serous EOC patients and 2 patients with other ovarian cancer histotypes (test set). The 43-gene predictor set properly classified serous EOC patients at high risk for early (≤22 months) versus late (>22 months) relapse after initial CT. Thus, gene expression array technology can effectively classify serous EOC tumors according to CT response. The proposed 43-gene model needs further validation. 2 condition experiment: chemoresistant clinical samples versus chemosensitive samples

2011-07-23 | E-GEOD-28739 | biostudies-arrayexpress

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy

2011-07-24 | GSE28739 | GEO

High throughput sequencing of small cell lung cancer chemosensitive H69 and corresponding chemoresistant H69AR

Project description:High throughput sequencing of small cell lung cancer chemosensitive H69 and corresponding chemoresistant H69AR

| PRJNA929197 | ENA

Gene differences between chemoresistant and chemosensitive variants of the human bladder cancer cell line T24

Project description:Gene differences between chemoresistant and chemosensitive variants of the human bladder cancer cell line T24

| PRJNA1335943 | ENA

Small RNA-sequencing of bone marrow samples from acute myeloid leukemia patients chemoresistant (n=27) versus chemosensitive (n=20).

Project description:Small RNA-sequencing of bone marrow samples from acute myeloid leukemia patients chemoresistant (n=27) versus chemosensitive (n=20).

| PRJEB36700 | ENA

Gene differences between chemoresistant and chemosensitive variants of the human bladder cancer cell line T24

Project description:The chemoresistant cell line was established using a concentration-gradient increment method. Transcriptome sequencing was performed after stable resistance was achieved to identify differentially expressed genes.

2026-03-11 | GSE309386 | GEO

Gene differences between chemoresistant and chemosensitive variants of the human bladder cancer cell line T24 [RNA-Seq UC3]

Project description:Gene differences between chemoresistant and chemosensitive variants of the human bladder cancer cell line T24 [RNA-Seq UC3]

| PRJNA1335941 | ENA

Gene differences between chemoresistant and chemosensitive variants of the human bladder cancer cell line T24 [RNA-Seq UC3]

2026-03-11 | GSE309388 | GEO